KMDA Q3 2023 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q3 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$38M+17.7% YoY

Gross Profit

$15M39.0% margin

Operating Income

$4M11.5% margin

Net Income

$3M8.5% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+1.3%

Cash Flow

Operating Cash Flow

$921,000

Free Cash Flow

-$808,000

Stock-Based Comp.

$312,000

Balance Sheet

Total Assets

$337M

Total Liabilities

$99M

Stockholders' Equity

$238M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$32M	+17.7%
Gross Profit	$15M	$13M	+15.0%
Operating Income	$4M	$3M	+70.5%
Net Income	$3M	$484,000	+565.9%